Blocklisting Interim Review

Intertek Group PLC
10 January 2006


SCHEDULE 5

BLOCKLISTING SIX MONTHLY RETURN

To: Listing Applications
UK Listing Authority
Financial Services Authority
25, The North Colonnade
Canary Wharf
London, E14 5HS

               Please ensure the entries on this return are typed

1. Name of company

Intertek Group plc

2. Name of scheme

  1.  1997 Unapproved Share Option Scheme (1997 U)
  2.  2002 Approved Share Option Scheme (2002 A)
  3.  2002 Unapproved Share Option Scheme (2002 U)

3. Period of return:

From: 11 July 2005                      To: 10 January 2006

4. Number and class of share(s) (amount of stock / debt security) not issued
under scheme

1997 U                     186,096 shares
2002 A                     139,344 shares
2002 U                     530,231 shares

                   Total   855,671 shares

5. Number of shares issued / allotted under scheme during period:

1997 U                     36,321 shares
2002 A                     38,214 shares
2002 U                     45,123 shares

                   Total   119,658 shares

6. Balance under scheme not yet issued / allotted at end of period

1997 U                     149,775 shares
2002 A                     101,130 shares
2002 U                     485,108 shares

                   Total   736,013 shares

7. Number and class of share(s) (amount of stock / debt securities) originally
listed and the date of admission;

1997 U         1,300,000 shares                     9 June 2004
2002 A         250,000 shares                       11 July 2002
2002 U         1,000,000 shares                     11 July 2002

       Total   2,550,000 shares

Please confirm total number of shares in issue at the end of the period in order
for us to update our records

155,391,218 shares

Contact for queries

Name
S C Hornbuckle

Address
25 Savile Row, London W1S 2ES

Telephone
0207 396 3442

Person making the return

Name
S C Hornbuckle

Position
Deputy Company Secretary

Signature
S C Hornbuckle

The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.




                      This information is provided by RNS
            The company news service from the London Stock Exchange